Review
Melatonin in Alzheimer’s Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer’s Neuropathology
Fecha
2019Registro en:
56, 12, 8255-8276
08937648
Autor
Hossain M.F.
Uddin M.S.
Uddin G.M.S.
Sumsuzzman D.M.
Islam M.S.
Barreto G.E.
Mathew B.
Ashraf G.M.
Institución
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Therapeutical implications of melatonin in Alzheimer´s and Parkinson´s diseases
Cardinali, Daniel Pedro; Vigo, Daniel Eduardo; Olivar, Natividad; Vidal, Maria Florencia; Brusco, Herminia Alicia (Springer, 2015)Neurodegenerative diseases like Alzheimer?s disease(AD) and Parkinson's disease (PD) are major health problems, and a growingrecognition exists that efforts to prevent them must be undertaken by bothgovernmental and ... -
Melatonin therapy in patients with Alzheimer’s disease
Cardinali, Daniel Pedro; Vigo, Daniel Eduardo; Olivar, Natividad; Vidal, Maria Florencia; Brusco, Luis Ignacio (Multidisciplinary Digital Publishing Institute, 2014-04)Alzheimer’s disease (AD) is a major health problem and a growing recognition exists that efforts to prevent it must be undertaken by both governmental and non-governmental organizations. In this context, the pineal product, ... -
Neuroendocrine-metabolic dysfunction and sleep disturbances in neurodegenerative disorders: Focus on Alzheimer's disease and melatonin
Spinedi, Eduardo Julio; Cardinali, Daniel Pedro (Karger, 2018-10)Alzheimer's disease (AD) is associated with altered eating behavior and metabolic disruption. Amyloid plaques and neurofilament tangles are observed in many hypothalamic nuclei from AD brains. Some of these areas ...